| # | Drug | Count |
|---|---|---|
| 0 | CISPLATIN | 240 |
| 1 | CARBOPLATIN | 208 |
| 2 | ETOPOSIDE | 149 |
| 3 | GENTAMICIN SULFATE | 99 |
| 4 | AMIKACIN | 85 |
| 5 | METHOTREXATE SODIUM | 85 |
| 6 | VANCOMYCIN HYDROCHLORIDE | 85 |
| 7 | VINCRISTINE SULFATE | 80 |
| 8 | VANCOMYCIN | 77 |
| 9 | METHOTREXATE | 76 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | GENTIAN VIOLET | 2 | 0.0556 |
| 1 | ERYTHROMYCIN STEARATE | 5 | 0.0327 |
| 2 | DACTINOMYCIN | 51 | 0.0235 |
| 3 | AMIKACIN SULFATE | 23 | 0.0201 |
| 4 | CEFOXITIN SODIUM | 15 | 0.0165 |
| 5 | PAROMOMYCIN SULFATE | 1 | 0.0149 |
| 6 | INTERLEUKIN-10 | 5 | 0.0129 |
| 7 | DINUTUXIMAB | 6 | 0.0126 |
| 8 | TOBRAMYCIN / DEXAMETHASONE | 1 | 0.0125 |
| 9 | BEDAQUILINE FUMARATE | 10 | 0.0113 |
| # | Drug class | Count |
|---|---|---|
| 0 | Platinum-based Drug [EPC] | 412 |
| 1 | Topoisomerase Inhibitor [EPC] | 150 |
| 2 | Aminoglycoside Antibacterial [EPC] | 145 |
| 3 | Alkylating Drug [EPC] | 120 |
| 4 | Macrolide Antimicrobial [EPC] | 103 |
| 5 | Corticosteroid [EPC] | 89 |
| 6 | Glycopeptide Antibacterial [EPC] | 85 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 74 |
| 8 | Nonsteroidal Anti-inflammatory Drug [EPC] | 72 |
| 9 | Oxazolidinone Antibacterial [EPC] | 60 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Actinomycin [EPC] | 51 | 0.0240 |
| 1 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 6 | 0.0111 |
| 2 | Antileishmanial [EPC] | 2 | 0.0090 |
| 3 | Tetracycline-class Antibacterial [EPC] | 21 | 0.0049 |
| 4 | Aminoglycoside Antibacterial [EPC] | 145 | 0.0048 |
| 5 | Penem Antibacterial [EPC] | 6 | 0.0047 |
| 6 | Rifamycin Antimycobacterial [EPC] | 7 | 0.0033 |
| 7 | Oxazolidinone Antibacterial [EPC] | 60 | 0.0032 |
| 8 | Topoisomerase Inhibitor [EPC] | 150 | 0.0032 |
| 9 | Platinum-based Drug [EPC] | 412 | 0.0025 |